Model Affitin and PEG modifications onto siRNA lipid nanocapsules: cell uptake and in vivo biodistribution improvements

DocumentFichier
Fichier pdf chargé le 11/09/2019 à 11:22:10
Accès identifié
(version éditeur)
Request
TitreModel Affitin and PEG modifications onto siRNA lipid nanocapsules: cell uptake and in vivo biodistribution improvements
Type de publicationArticle de revue
AuteurResnier, Pauline , Lepeltier, Elise , Emina, Anthea Lucrezia , Galopin, Natacha , Bejaud, Jérôme , David, Stephanie , Ballet, Caroline , Benvegnu, Thierry , Pecorari, Frédéric , Chourpa, Igor , Benoît, Jean-Pierre , Passirani-Malleret, Catherine
TypeArticle scientifique dans une revue à comité de lecture
Année2019
Date2019
Pagination27264-78
Volume9
Titre de la revueRSC Advances
Résumé en anglais

Malignantmelanoma is an aggressive tumor, associated with the presence of local and/or distant metastases. The development of gene therapy by the use of small interfering RNA (siRNA) represents a promising new treatment. However, the protection of this biomolecule is necessary in order for it to be intravenously administrated, for example via its incorporation into nanomedicines. In parallel to the passive targeting usually obtained by pegylation, various studies have aimed at developing “smart” nanomedicines to efficiently deliver the drug to tumor sites. In this work, siRNA loaded lipid nanocapsules (LNCs) were modified with DSPE-polyethylene glycol (DSPE-PEG), tetraether-PEG (TE-PEG) and/or with an Affitin model, to assay multiple targeting strategies. The uptake of fluorescently labelled LNCs, nanocarrier integrity and siRNA release into human SKMel28 melanoma cells were studied by flow cytometry, conventional confocal microscopy and by confocal spectral imaging in a Forster Resonance Energy Transfer (FRET) mode. Surface modified siRNA LNCs were followed after human plasma incubation and after intravenous injection, in order to compare the stealth properties. Finally, the biodistribution of the different siRNA LNCs in healthy and melanoma tumor bearing
mice models was assessed by in vivo biofluorescence imaging (BFI), to evaluate the potential tumor targeting ability. The post-insertion of DSPE-PEG induced a strong decrease of the internalization into melanoma cells compared to TE-PEG modification. Both PEG polymer decorations induced a great plasma protection of siRNA but only DSPE-PEG led to stealth properties, even at low concentration (5 mM). The Affitin grafting by thiolation of DSPE-PEG was validated on siRNA LNCs. DSPE-PEG-Affitin LNCs were not detected in this melanoma tumor model but did not show unspecific accumulation in organs. DSPE-PEG and TE-PEG LNCs induced a significant intratumoral accumulation of modified LNCs.

URL de la noticehttp://okina.univ-angers.fr/publications/ua20178
DOI10.1039/c9ra03668g
Titre abrégéRSC Adv.